Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06927076

Antidepressant Response of DMT Masked With Propofol

Investigating the Role of the Psychedelic Experience in the Antidepressant Response in Patients With Major Depression: a Placebo-controlled Factorial Trial With DMT Masked With Propofol (DMT4D-Study)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
112 (estimated)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to elucidate if the anti-depressive effect of N,N-dimethyltryptamine (DMT) is based on a biological mechanisms including neuroplasticity and anti-inflammatory effect or due to the subjective psychedelic experience.

Detailed description

Major depressive disorder (MDD) affects nearly 20% of people, but current treatments-both pharmacological and psychotherapeutic-have limited efficacy, especially for mild to severe cases. Psychedelics like LSD, psilocybin, and DMT are being explored as alternative therapies, with studies showing promising antidepressant effects. However, it is unclear whether these benefits stem from their acute subjective (psychedelic) experience or from biological mechanisms like neuroplasticity and anti-inflammatory effects. This study aims to determine if the antidepressant effects of DMT occur independently of its psychedelic experience. To test this, DMT will be administered under sedation (with propofol) to mask subjective effects, as well as without sedation.

Conditions

Interventions

TypeNameDescription
DRUGN,N-Dimethyltryptamineadministration of a 2mg/min DMT perfusion over 20 min
DRUGPlaceboadministration of a placebo perfusion over 20 min
PROCEDUREPropofol30 min propofol sedation
PROCEDUREno sedationno sedation

Timeline

Start date
2025-08-05
Primary completion
2029-03-01
Completion
2029-03-01
First posted
2025-04-15
Last updated
2026-04-02

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT06927076. Inclusion in this directory is not an endorsement.